Target Name: H3-3A
NCBI ID: G3020
Review Report on H3-3A Target / Biomarker Content of Review Report on H3-3A Target / Biomarker
H3-3A
Other Name(s): H3 histone, family 3A | H3 histone family member 3A | BRYLIB1 | H3-3B | H3.3 histone A | H3.3A | H3F3A | H3-3A variant 1 | H3.3 histone A, transcript variant 1 | H3 histone family 3A | H3F3 | H33_HUMAN | Histone H3.3

H3-3A: A Potential Drug Target and Biomarker

H3-3A is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. Its function is not well understood, but it is known to play a role in the regulation of inflammation and cellular signaling. As a result, H3-3A has potential as a drug target and biomarker.

One of the key functions of H3-3A is its role in the regulation of inflammation. Chronic inflammation can lead to a host of diseases, including heart disease, diabetes, and cancer. H3-3A has been shown to play a role in reducing inflammation by regulating the activity of immune cells and suppressing the production of pro-inflammatory cytokines.

In addition to its role in inflammation, H3-3A is also involved in the regulation of cellular signaling. It has been shown to play a role in the regulation of cell proliferation and differentiation, as well as in the regulation of cell survival.

H3-3A is also of interest as a potential biomarker for several diseases, including heart disease, diabetes, and cancer. Its role in these processes makes it an attractive target for drug development.

One way to study the potential of H3-3A as a drug target is through the use of techniques such as RNA interference and live cell assays. These methods can be used to determine the effects of potential drugs on H3-3A expression and its function.

Another way to study the potential of H3-3A as a biomarker is through the use of techniques such as protein array and mass spectrometry. These methods can be used to identify and quantify the expression of H3-3A in various tissues and cells, as well as to determine the effects of potential drugs on its expression.

In conclusion, H3-3A is a protein that has the potential to be a drug target and biomarker. Its role in the regulation of inflammation and cellular signaling, as well as its potential as a biomarker for several diseases, make it an attractive target for further study. Further research is needed to fully understand its function and potential as a drug and biomarker.

Protein Name: H3.3 Histone A

Functions: Variant histone H3 which replaces conventional H3 in a wide range of nucleosomes in active genes. Constitutes the predominant form of histone H3 in non-dividing cells and is incorporated into chromatin independently of DNA synthesis. Deposited at sites of nucleosomal displacement throughout transcribed genes, suggesting that it represents an epigenetic imprint of transcriptionally active chromatin. Nucleosomes wrap and compact DNA into chromatin, limiting DNA accessibility to the cellular machineries which require DNA as a template. Histones thereby play a central role in transcription regulation, DNA repair, DNA replication and chromosomal stability. DNA accessibility is regulated via a complex set of post-translational modifications of histones, also called histone code, and nucleosome remodeling

The "H3-3A Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about H3-3A comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

H3-3B | H3-4 | H3-5 | H3-7 | H3C1 | H3C10 | H3C11 | H3C12 | H3C13 | H3C14 | H3C15 | H3C2 | H3C3 | H3C4 | H3C6 | H3C7 | H3C8 | H3P16 | H3P36 | H3P37 | H3P44 | H3P5 | H3P6 | H4C1 | H4C11 | H4C12 | H4C13 | H4C14 | H4C15 | H4C16 | H4C2 | H4C3 | H4C4 | H4C5 | H4C6 | H4C7 | H4C8 | H4C9 | H6PD | HAAO | HABP2 | HABP4 | HACD1 | HACD2 | HACD3 | HACD4 | HACE1 | HACL1 | HADH | HADHA | HADHAP1 | HADHB | HAFML | HAGH | HAGHL | HAGLR | HAGLROS | HAL | HAMP | HAND1 | HAND2 | HAND2-AS1 | HAO1 | HAO2 | HAO2-IT1 | HAP1 | HAPLN1 | HAPLN2 | HAPLN3 | HAPLN4 | HAPSTR1 | HAR1A | HAR1B | HARBI1 | HARS1 | HARS2 | HAS1 | HAS2 | HAS2-AS1 | HAS3 | HASPIN | HAT1 | HAUS1 | HAUS1P1 | HAUS2 | HAUS3 | HAUS4 | HAUS5 | HAUS6 | HAUS7 | HAUS8 | HAVCR1 | HAVCR1P1 | HAVCR2 | HAX1 | HAX1P1 | HBA1 | HBA2 | HBAP1 | HBB